How to read this list
Rank
Position in the Top 22, sorted by audience size from largest to smallest. Updated weekly.
Audience size
Estimated number of unique people in Japan who actively engage with this audience, derived from anonymized search-behavior signals.
Country share
Share of the global audience that is active in Japan. A higher value means the audience is more locally concentrated here.
Avg age
Average age in years across the people who engage with this audience in Japan, derived from anonymized search-behavior signals. A dash means demographic data is not yet available.
Female share
Share of women among the people who engage with this audience in Japan. 50% is gender-balanced; values above mean female-skewed, below mean male-skewed.
Ranking
| Rank | Audience | Audience size | Country share | Avg age | Female share | Subtype |
|---|---|---|---|---|---|---|
| 1 |  Amway |
438k | 3.4% | 38.1 | 61.6% | Medicine |
| 2 |  Bayer |
263k | 3.0% | 31.6 | 64.5% | Medicine |
| 3 |  Pfizer |
133k | 0.9% | 24.8 | 82.8% | Medicine |
| 4 |  BASF |
130k | 2.5% | 41.4 | 39.8% | Medicine |
| 5 |  Herbalife |
127k | 0.8% | 36.5 | 51.0% | Medicine |
| 6 |  Novartis |
103k | 1.4% | 40.1 | 45.2% | Medicine |
| 7 |  Novo Nordisk |
82k | 0.8% | 30.9 | 30.0% | Medicine |
| 8 |  Merck & Co. |
82k | 1.9% | 36.6 | 43.1% | Medicine |
| 9 |  Abbott Laboratories |
78k | 1.6% | 34.5 | 40.4% | Medicine |
| 10 |  Dr. Scholl's |
66k | 2.2% | 38.7 | 56.6% | Medicine |
| 11 |  Sanofi |
56k | 1.0% | 38.7 | 50.9% | Medicine |
| 12 |  Boehringer Ingelheim |
54k | 1.5% | 39.6 | 47.5% | Medicine |
| 13 |  Bristol-Myers Squibb |
49k | 2.5% | 49.4 | 35.5% | Medicine |
| 14 |  Naloxone |
23k | 2.3% | 41.9 | 61.4% | Medicine |
| 15 |  Shaklee |
14k | 1.6% | 43.8 | 77.7% | Medicine |
| 16 |  Doppelherz |
8k | 0.6% | 40.5 | 71.3% | Medicine |
| 17 |  Polydimethylsiloxane |
5.6k | 5.3% | 28.9 | 59.5% | Medicine |
| 18 |  Varilux |
3.7k | 0.7% | 42.7 | 66.7% | Medicine |
| 19 |  ThermaCare |
750 | 0.2% | 43.4 | 49.7% | Medicine |
| 20 |  Bausch & Lomb |
383 | 0.1% | 37.0 | 63.0% | Medicine |
| 21 |  Meridol |
383 | 0.1% | 37.5 | 66.2% | Medicine |
| 22 |  GlaxoSmithKline |
286 | 0.0% | 32.3 | 60.5% | Medicine |
Want the full picture for any of these audiences?
Open any profile to see psychographics, top regions, peer affinities and demographic splits — all derived from the same anonymized signals.
Frequently asked questions
How is this Top 22 list compiled?
Rascasse aggregates anonymized search-behavior signals across Japan and ranks each medicine by its estimated audience size. Only entries with at least 5 measured entities are listed.
How often is the list updated?
The ranking is refreshed weekly from the latest search-behavior data and re-published as a static page.
What is the largest medicine in Japan?
Amway currently leads with an estimated audience of 438k people in Japan.